Statistical Controversies in Clinical Research: An initial evaluation of a surrogate endpoint using a single randomized clinical trial and the prentice criteria

Surrogate endpoint research has grown in recent years with the increasing development and usage of biomarkers in clinical research. Surrogacy analysis is derived through randomized clinical trial data and it is performed at the individual level and at the trial level.

A common surrogate analysis at the individual level is the application of the Prentice criteria. An approach for the evaluation of the Prentice criteria is discussed, with a focus on its most difficult component, the determination of whether the treatment effect is captured by the surrogate. An interpretation of this criterion is illustrated using data from a randomized clinical trial in prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Aug 07 [Epub ahead of print]

G Heller

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY USA.



Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.